Ubidecarenone Capsules, chemical structure, molecular formula, Reference Standards
»Ubidecarenone Capsules contain not less than 90.0percent and not more than 115.0percent of the labeled amount of ubidecarenone (C59H90O4).
Packaging and storage
Preserve in tight,light-resistant containers.
USP Reference standards á11ñ
USP Ubidecarenone RS.
The retention time of the major peak in the chromatogram of either Assay preparation 1or Assay preparation 2corresponds to that in the chromatogram of the Standard preparation,as obtained in the Assay.
Disintegration and dissolution á2040ñ:
meet the requirements of the test for Disintegrationonly.
Weight variation á2091ñ:
meet the requirements.
Change to read:
[NOTEConduct this test promptly with minimum exposure to actinic light.]
Prepare a mixture of n-hexane and dehydrated alcohol (5:2).
Prepare a filtered and degassed mixture of acetonitrile,tetrahydrofuran,and water (55:40:5).Make adjustments if necessary (see System Suitabilityunder Chromatography á621ñ).
Dissolve an accurately weighed quantity of USP Ubidecarenone RSin Solventto obtain a solution having a known concentration of 1.0mg per mL.Dilute a portion of this solution with dehydrated alcohol to obtain a solution having a known concentration of about 40µg per mL.
Dissolve an accurately weighed quantity of coenzyme Q9in Solventto obtain a solution having a concentration of 1.0mg per mL.Dilute a portion of this solution with dehydrated alcohol to obtain a solution having a concentration of about 40µg per mL.Mix equal volumes of this solution and the Standard preparation.
Assay preparation 1(for soft gelatin Capsules)
Using a suitable cutting instrument,open an accurately counted number of Capsules,equivalent to about 200mg of ubidecarenone.Quantitatively transfer the shells and contents to a suitable container,add 100mLof Solvent,and shake by mechanical means for 30minutes.Using small portions of Solvent,quantitatively transfer this mixture to a 200-mLvolumetric flask,dilute with Solventto volume,and mix.Centrifuge a portion of this solution,transfer 1.0mLof the supernatant to a 25-mLvolumetric flask,add 2.5mLof a 0.1%solution of anhydrous ferric chloride in alcohol,dilute with alcohol to volume,USP28and mix.
Assay preparation 2(for hard gelatin Capsules)
Empty and thoroughly mix the contents of not fewer than 20Capsules.Transfer an accurately weighed portion of the powder,equivalent to about 100mg of ubidecarenone,to a 100-mLvolumetric flask,add 60mLof Solvent,and shake by mechanical means for 30minutes.Dilute with Solventto volume,and mix.Centrifuge a portion of this solution,transfer 1.0mLof the supernatant to a 25-mLvolumetric flask,add 2.5mLof a 0.1%solution of anhydrous ferric chloride in alcohol,dilute with alcohol to volume,and mix.
Chromatographic system (see Chromatography á621ñ)
The liquid chromatograph is equipped with a 280-nm detector and an 8-mm ×10-cm column that contains packing L1.The flow rate is about 2.5mLper minute.Chromatograph the Resolution solution,and record the peak responses as directed for Procedure:the resolution,R,between ubidecarenone and coenzyme Q9is not less than 2.5.Chromatograph the Standard preparation,and record the peak responses as directed for Procedure:the tailing factor is not more than 1.5;and the relative standard deviation for replicate injections is not more than 2.0%.
Separately inject equal volumes (about 15µL)of the Standard preparationand Assay preparation 1or Assay preparation 2into the chromatograph,record the chromatograms,and measure the responses for the major peaks.Calculate the quantity,in mg,of ubidecarenone (C59H90O4)in each soft gelatin Capsule taken by the formula:
in which Cis the concentration,in mg per mL,of USP Ubidecarenone RSin the Standard preparation;Nis the number of Capsules taken to prepare Assay preparation 1;and rUand rSare the peak responses obtained from Assay preparation 1and the Standard preparation,respectively.Calculate the quantity,in mg,of ubidecarenone (C59H90O4)in the portion of hard gelatin Capsules taken by the formula:
in which rUis the peak response obtained from Assay preparation 2;and the other terms are as defined herein.
Staff Liaison:Lawrence Evans,III,Ph.D.,Scientist
Expert Committee:(DSN)Dietary Supplements:Non-Botanicals
Pharmacopeial Forum:Volume No.30(1)Page 202
信息录入：awin 责任编辑：awin 【发表评论